Related Experiment Video
Updated: Apr 4, 2026

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
Protein N-homocysteinylation: From cellular toxicity to neurodegeneration
Gurumayum Suraj Sharma1, Tarun Kumar1, Tanveer Ali Dar2
1Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India.
Background:
Homocysteine (Hcy) is a sulfur containing non-protein amino acid that occupies a central role in metabolism of thiol compounds. The past decade had noticed an explosion in interests of Hcy and this very interest came primarily from the fact that increased Hcy level is related to various neurodegenerative and vascular complications.
Scope Of Review:
Several factors responsible for the Hcy-associated neurotoxicity have been proposed and well documented in literature, including oxidative stress and apoptosis. In addition, protein covalent modification by the metabolite of Hcy, Hcy thiolactone (HTL), has now been shown to be another cause of cellular Hcy toxicity. This mechanism, termed as "protein N-homocysteinylation", is known to result in protein denaturation, enzyme inactivation and even amyloid formation. The role of protein N-homocysteinylation and the resulting consequences with regard to neurodegeneration have not yet been extensively discussed. The present review describes major advances in understanding protein N-homocysteinylation and their role in neurodegeneration.
Major Conclusions:
Formation of protein aggregates/amyloids are crucial events in various human pathologies including neurodegenerative diseases. Since elevated Hcy has been closely linked to neurodegeneration, N-homocysteinylation-induced protein modification and aggregates/amyloids formation could be one possible mechanism for the neurodegenerative conditions.
General Significance:
The information highlighted here provides us an understanding of the role protein modification by N-homocysteinylation in neurodegenerative diseases.
Related Concept Videos
Bioactivation and Tissue Toxicity
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Drug Toxicity: Dose-Dependent Reactions
Biosynthesis of Nucleic Acids
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

